Treatments with agonists of THR-β, which is the main receptor for TH in the liver, have also been tried to reduce cholesterol levels [56] or for the treatment of non-alcoholic steatohepatitis [57]. The gene discussed is THRB; the disease is metabolic dysfunction-associated steatohepatitis.